maxaquin- lomefloxacin hydrochloride tablet, film coated
g.d. searle llc - lomefloxacin hydrochloride (unii: 9vc7s3zxxb) (lomefloxacin - unii:l6br2wjd8v) - tablet, film coated - 400 mg - maxaquin (lomefloxacin hcl) film-coated tablets are indicated for the treatment of adults with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below: (see dosage and administration for specific dosing recommendations.) acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae or moraxella catarrhalis. 1 note: maxaquin is not indicated for the empiric treatment of acute bacterial exacerbation of chronic bronchitis when it is probable that s pneumoniae is a causative pathogen. s pneumoniae exhibits in vitro resistance to lomefloxacin, and the safety and efficacy of lomefloxacin in the treatment of patients with acute bacterial exacerbation of chronic bronchitis caused by s pneumoniae have not been demonstrated. if lomefloxacin is to be prescribed for gram–stain–guided empiric therapy of acute bacterial exacerbation of chronic bronchitis, it should be used only if sputum gram stain demonstrates an adequate qualit
moxifloxacin hydrochloride- moxifloxacin hydrochloride tablet, film coated
alvogen, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg - moxifloxacin hydrochloride is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. moxifloxacin hydrochloride is indicated in
moxifloxacin hydrochloride- moxifloxacin hydrochloride tablet, film coated
pd-rx pharmaceuticals, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg - moxifloxacin hydrochloride is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]) , haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies ( 14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies ( 14.4 )]. moxifloxacin hydrochloride is indica
moxifloxacin hydrochloride tablet
novel laboratories, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg - moxifloxacin hydrochloride is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3)] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4)]. moxifloxacin hydrochloride is indicated in ad
moxifloxacin hydrochloride tablet, film coated
pd-rx pharmaceuticals, inc. - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin hydrochloride is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]) , haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies ( 14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. moxifloxacin hydrochloride is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible
bareon tablets 200mg (バレオン錠200mg)
mylan epd g.k. - lomefloxacin hydrochloride - white tablet with split line, diameter: approx. 9.1 mm, thickness: approx. 4.3 mm - it is usually used in the treatment of wide-range infections such as respiratory infections, urinary tract infections and otorhinological infections.
bareon capsules 100mg (バレオンカプセル100mg)
mylan epd g.k. - lomefloxacin hydrochloride - white capsule (length: approx. 15.9 mm, diameter: approx. 5.8 mm) - it is usually used in the treatment of wide-range infections such as respiratory infections, urinary tract infections and otorhinological infections.
maxaquin
pharmacia limited company trading as pharmacia - lomefloxacin hydrochloride 400mg; - tablet - 400 mg - active: lomefloxacin hydrochloride 400mg
lomeflon minims solution for eye and ear0.3% [ophthalmology] (ロメフロンミニムス眼科耳科用液0.3%[眼科])
senju pharmaceutical co.,ltd. - lomefloxacin hydrochloride - limpid and colorless ophthalmic solution, (volume) 0.5ml - it is usually used in the treatment of eye infections such as conjunctivitis and hordeolum, and for the sterilization before and after eye surgery.
lomeflon minims solution for eye and ear0.3% [otology] (ロメフロンミニムス眼科耳科用液0.3%[耳科])
senju pharmaceutical co.,ltd. - lomefloxacin hydrochloride - limpid and colorless ear solution, (volume) 0.5ml - it is usually used in the treatment of otitis externa and otitis media.